EpCAM a proteolytically cleaved oncogene and an excellent therapeutic target in cancer;EpCAM, une protéine versatile impliquée dans l'oncogenèse

Medecine/Sciences

Volumn 25, Issue 5, 2009, Pages 449-450

  Gires, Olivier ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADECATUMUMAB; BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; MEMBRANE PROTEIN; PRESENILIN 2; RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VACCINE;

ANTIGEN PURIFICATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CYTOPLASM; CYTOTOXICITY; GENE SILENCING; IMMUNITY; NOTE; ONCOGENE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 66849087512     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2009255449     Document Type: Note

References (13)

1. Herlyn D, Herlyn M, Steplewski Z, Koprowski H. Monoclonal antibodies in cell-mediated cytotoxicity against human melanoma and colorectal carcinoma. Eur J Immunol 1979 ; 9 : 657-659 (Pubitemid 10225217)
2. Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer 2007 ; 96 : 417-423
3. Balzar M, Briaire-de Bruijn IH, Rees-Bakker HA, et al. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions. Mol Cell Biol 2001 ; 21 : 2570-2580 (Pubitemid 32222108)
4. Balzar M, Winter MJ, de Boer CJ, Litvinov SV. The biology of the 17-1A antigen (Ep-CAM). J Mol Med 1999 ; 77 : 699-712.
5. Litvinov SV, Bakker HA, Gourevitch MM, Velders MP, Warnaar SO. Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell 8. adhesion. Cell Adhes Commun 2001 ; 2 : 417-428
6. Litvinov SV, Balzar M, Winter MJ, et al. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic Cadherins. J Cell Biol 1997 ; 139 : 1337-1348 (Pubitemid 27523219)
7. Osta WA, Chen Y, Mikhitarian K, et al. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 2004 ; 64 : 5818-5824 (Pubitemid 39095582)
8. Munz M, Kieu C, Mack B, et al. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 2004 ; 23 : 5748-5758 (Pubitemid 39093020)
9. Maetzel D, Denzel S, Mack B, et al. Nuclear signalling by tumour-associated antigen EpCAM. Nat Cell Biol 2009 ; 11 : 162-171
10. Carpenter G, Red Brewer M. EpCAM: another surface-to-nucleus missile. Cancer Cell 2009 ; 15 : 165-166
11. Gires O, Klein CA, Baeuerle PA. On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer 2009 ; 9 : 143 ; 143.
12. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008 ; 8 : 755-768
13. Kastner P, Chan S. La voie Notch au centre du mécanisme de leucémogenèse dans un modèle murin de leucémies T. Med Sci (Paris) 2006 ; 22 : 708-710